Status:
COMPLETED
Efficacy of the Pre-Admission Medication List (PAML) Builder Reminder Prompts
Lead Sponsor:
Brigham and Women's Hospital
Collaborating Sponsors:
Massachusetts General Hospital
Conditions:
Utilization of Software Application Features
Eligibility:
All Genders
Phase:
NA
Brief Summary
This project will study whether reminder prompts increase PAML Builder application feature utilization.
Detailed Description
This project will study whether reminder prompts increase Pre-Admission Medication List (PAML) Builder application feature utilization. PAML Builder is an application designed and maintained by Partne...
Eligibility Criteria
Inclusion
- users of the PAML Builder application (physicians, nurses, pharmacists)
Exclusion
- none
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
14122 Patients enrolled
Trial Details
Trial ID
NCT00657462
Start Date
April 1 2008
End Date
July 1 2008
Last Update
January 31 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
2
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115